Five studies differentiated the immunohistochemical expressions of BRAF V600E between conventional and unicystic ameloblastomas, of which three (60%) demonstrated that the unicystic types exhibited higher positivity compared to the conventional ones. This evidence concerns the gene BRAF and ameloblastoma.